MAPT and Alzheimer disease: Over the past few decades, researchers have shown in longitudinal studies that Aβ accumulation precedes tau pathology in AD brains and that AD brain-derived soluble Aβ induces tau hyperphosphorylation which precedes tau aggregation [3, 4].